Paper · 40407337
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 35
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35969055 | A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/35969055 | PubMed |
| 2 | 25568071 | Direct inhibitors of InhA are active against Mycobacterium tuberculosis. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25568071 | PubMed |
| 3 | 22290346 | Mycobacterium abscessus: a new antibiotic nightmare. | J Antimicrob Chemother | 2012 | https://conductscience.org/library/papers/22290346 | PubMed |
| 4 | 8284673 | inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. | Science | 1994 | https://conductscience.org/library/papers/8284673 | PubMed |
| 5 | 31507579 | Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease. | Front Microbiol | 2019 | https://conductscience.org/library/papers/31507579 | PubMed |
| 6 | 30689764 | Mycobacterium abscessus and Antibiotic Resistance: Same As It Ever Was. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/30689764 | PubMed |
| 7 | 29712658 | Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29712658 | PubMed |
| 8 | 32317266 | KatG as Counterselection Marker for Nontuberculous Mycobacteria. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32317266 | PubMed |
| 9 | 32086501 | Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. | Nat Rev Microbiol | 2020 | https://conductscience.org/library/papers/32086501 | PubMed |
| 10 | 28575382 | In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis. | J Antimicrob Chemother | 2017 | https://conductscience.org/library/papers/28575382 | PubMed |
| 11 | 21292749 | Deletion of the mmpL4b gene in the Mycobacterium abscessus glycopeptidolipid biosynthetic pathway results in loss of surface colonization capability, but enhanced ability to replicate in human macrophages and stimulate their innate immune response. | Microbiology (Reading) | 2011 | https://conductscience.org/library/papers/21292749 | PubMed |
| 12 | 29437627 | Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29437627 | PubMed |
| 13 | 30880280 | M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis. | Eur Respir J | 2019 | https://conductscience.org/library/papers/30880280 | PubMed |
| 14 | 26488279 | Assembly of the Mycobacterial Cell Wall. | Annu Rev Microbiol | 2015 | https://conductscience.org/library/papers/26488279 | PubMed |
| 15 | 29277667 | Triclosan and its derivatives as antimycobacterial active agents. | Eur J Pharm Sci | 2018 | https://conductscience.org/library/papers/29277667 | PubMed |
| 16 | 32314749 | Fast chemical force microscopy demonstrates that glycopeptidolipids define nanodomains of varying hydrophobicity on mycobacteria. | Nanoscale Horiz | 2020 | https://conductscience.org/library/papers/32314749 | PubMed |
| 17 | 37314394 | New therapeutic strategies for Mycobacterium abscessus pulmonary diseases - untapping the mycolic acid pathway. | Expert Rev Anti Infect Ther | 2023 | https://conductscience.org/library/papers/37314394 | PubMed |
| 18 | 32636299 | Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. | Eur Respir J | 2020 | https://conductscience.org/library/papers/32636299 | PubMed |
| 19 | 19171799 | A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19171799 | PubMed |
| 20 | 24752273 | Lack of antimicrobial bactericidal activity in Mycobacterium abscessus. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24752273 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/40407337/references